Logo

OST

Ostin Technology Group Co., Ltd.

OST

Ostin Technology Group Co., Ltd. • NASDAQ
$1.70 ▼ -0.29% (-0.01)
Market Cap $8.98 M
52w High $235.00
52w Low $1.35
Dividend Yield 0%
P/E -0.01
Volume 57.05K
Outstanding Shares 5.30M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $20.843M ▲ $6.778M ▲ $-5.179M ▲ -24.85% ▲ $-74.58 ▼ $-2.965M ▲
Q4-2024 $17.49M ▲ $6.533M ▲ $-5.42M ▼ -30.991% ▲ $-3.86 ▼ $-3.174M ▼
Q2-2024 $14.973M ▼ $4.682M ▼ $-4.641M ▲ -30.997% ▼ $-0.3 ▲ $-2.635M ▲
Q4-2023 $23.231M ▼ $6.572M ▲ $-5.96M ▼ -25.654% ▼ $-0.43 ▼ $-3.258M ▼
Q2-2023 $34.295M $5.932M $-4.989M -14.548% $-0.36 $-3.144M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $1.7M ▲ $52.596M ▲ $46.787M ▲ $2.679M ▼
Q4-2024 $1.025M ▼ $51.075M ▼ $43.188M ▲ $5.192M ▼
Q2-2024 $1.745M ▲ $51.441M ▼ $39.778M ▼ $10.285M ▼
Q4-2023 $854.518K ▼ $56.549M ▼ $42.461M ▲ $13.958M ▼
Q2-2023 $2.62M $57.677M $37.49M $19.948M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $-5.179M ▲ $0 ▲ $0 ▲ $0 ▼ $0 $0 ▲
Q4-2024 $-5.42M ▼ $-1.049M ▲ $-1.128M ▼ $1.544M ▼ $0 ▼ $-2.854M ▲
Q2-2024 $-4.641M ▲ $-3.893M ▼ $-263.38K ▲ $5.201M ▲ $446.643K ▲ $-4.509M ▲
Q4-2023 $-5.96M ▼ $-3.166M ▼ $-2.097M ▲ $3.174M ▼ $-1.785M ▼ $-5.406M ▼
Q2-2023 $-4.989M $574.718K $-4.894M $4.547M $-864.719K $-4.686M

Revenue by Products

Product Q3-2023
Others Member
Others Member
 $0 ▲

Five-Year Company Overview

Income Statement

Income Statement Ostin’s income picture is very weak. Sales have been shrinking steadily over the last few years, and the company is now operating at a very small scale. Gross profit is close to break-even, which means there is very little room to cover overhead costs. Operating results and net income have slipped into small but persistent losses, showing a business that is struggling to reach sustainable profitability. The wild swings in reported earnings per share mainly reflect share structure changes rather than a true improvement in the underlying business.

Balance Sheet

Balance Sheet The balance sheet is thin and fragile. The company has only a modest asset base, carries some debt, and shows a relatively small equity cushion. Reported cash is essentially negligible, which raises clear questions about liquidity and resilience if conditions worsen. Overall, the financial structure looks stretched, with limited room to absorb shocks or fund growth internally.

Cash Flow

Cash Flow Cash generation is marginal at best. Operating cash flow has hovered around break-even, occasionally slightly positive, but not strong or consistent. Free cash flow has generally been negative once basic investment needs are factored in, suggesting the business is not yet self-funding. With very limited cash on hand, ongoing negative free cash flow increases financial risk and dependence on outside funding or very tight cost control.

Competitive Edge

Competitive Edge Competitively, Ostin is a small player in a tough, price-sensitive hardware market dominated by much larger display manufacturers. Its ability to customize display modules offers a niche angle, and the Pintura consumer product line gives it a differentiated, design-focused story. However, the company’s small scale, intense industry competition, and serious legal and governance issues (including an indictment of its co-CEO and Nasdaq listing pressures) significantly weaken its overall competitive standing and make customer and partner trust a major concern. Any existing moat appears narrow and vulnerable.

Innovation and R&D

Innovation and R&D On the innovation side, Ostin is trying to pivot from being mainly a components supplier to a more consumer-facing electronics brand. The Pintura digital frame concept – modular panoramic displays, cordless magnetic mounting, interactive functions, and planned AI photo features – shows creativity and some product vision. Custom TFT-LCD solutions for specialized uses also point to technical capability. However, the scale, consistency, and funding of its R&D efforts are unclear, and the commercial success of these products is not yet established. Innovation is present, but it sits on a weak financial and governance foundation, which may limit how far it can go.

Summary

Overall, Ostin looks like a very small, financially fragile technology manufacturer attempting a higher-margin consumer electronics pivot under difficult circumstances. The core numbers show shrinking revenue, razor-thin or negative profitability, limited assets, almost no cash buffer, and weak cash generation. At the same time, the company is trying to differentiate with visually appealing, feature-rich display products. Serious legal issues, corporate governance concerns, and repeated reverse stock splits overshadow the product story and create substantial uncertainty around long-term viability. Observers would likely view this as a high-risk situation where innovation and financial distress are unfolding side by side.

NEWS

November 25, 2025 · 9:21 AM UTC

OS Therapies Receives Non-Proprietary Name 'daznelimgene lisbac' for OST-HER2 from World Health Organization

Read more

October 22, 2025 · 9:15 AM UTC

OS Therapies Announces Overall and Event Free Survival Key Subgroup Data for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma

Read more

October 10, 2025 · 6:00 AM UTC

OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully-Resected, Pulmonary Metastatic Osteosarcoma

Read more

September 30, 2025 · 7:40 AM UTC

OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update

Read more

September 12, 2025 · 7:40 AM UTC

OS Therapies Announces Last Patient Enrolled in OST-504 (previously ADXS-504) Phase 1b Prostate Cancer Clinical Trial Completes Last Visit

Read more